Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME Globotriosylceramide hydrolytic enzyme DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Fabry Disease 4 D000795 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
15.32
Nervous system disorders
11.71
Cardiac disorders
8.11
Gastrointestinal disorders
7.84
Vascular disorders
6.83
Respiratory, thoracic and mediastinal disorders
6.81
Infections and infestations
5.95
Skin and subcutaneous tissue disorders
5.62
Musculoskeletal and connective tissue disorders
5.32
Investigations
5.17
Injury, poisoning and procedural complications
4.76
Psychiatric disorders
4.26
Renal and urinary disorders
2.51

Cross References

Resources Reference
CAS NUMBER 104138-64-9
ChEMBL CHEMBL2108888
FDA SRS RZD65TSM9U